Upgrade to SI Premium - Free Trial

Sandoz (NVS) Receives Positive EMA CHMP Opinion on Pregabalin as Epilepsy and GAD Treatment

April 24, 2015 7:53 AM
On 23 April 2015, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA

Next Articles